Lixte Biotechnology Holdings, Inc. Common Stock
$7.285
USD
Last updated on --.
24h volume610.70K
24h highest8.1750 USD
24h lowest7.0400 USD
24h Price movement+1.04%
LIXT recent prices
24 Hours
+1.04%+$0.075
30 days
+1.04%+$0.075
60 days
+5.73%+$0.395
90 days
+41.46%+$2.135
Key data
Previous close7.2100 USD
Market cap125.36M USD
Volume610.70K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.42000 USD
Net income (FY)-7.29M USD
Revenue (FY)--
Last report dateMay 14, 2026
About Lixte Biotechnology Holdings, Inc. Common Stock
HeadquartersBOCA RATON
Employees (FY)3.00
Net income per employee (FY)-2.43M USD
Listed onNasdaq
LIXT conversion tables
 |  |
|---|---|
| 0.5 LIXT | 3.642 USD |
| 1 LIXT | 7.285 USD |
| 5 LIXT | 36.42 USD |
| 10 LIXT | 72.85 USD |
| |
|---|---|
| 0.5 USD | 0.068634 LIXT |
| 1 USD | 0.13727 LIXT |
| 5 USD | 0.68634 LIXT |
| 10 USD | 1.372 LIXT |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
LIXT is trading at $7.285, +1.04% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LIXT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LIXT is currently trading at $7.285, +1.04% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LIXT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LIXT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LIXT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LIXT's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Lixte Biotechnology Holdings, Inc. Common Stock's market cap is currently 125.36M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume610.70K
24h highest8.1750 USD
24h lowest7.0400 USD
24h Price movement+1.04%
Start trade with LIXT Perpetual
Sign up to trade